Baltimore’s Personal Genome Diagnostics Secures $103 Million in Financing

Personal Genome Diagnostics Secures $103 Million in Financing
Published on :

Cancer genomics company Personal Genome Diagnostics Inc. (PGDx) secured $103 million in a Series C financing round. Proceeds from the financial infusion will be used to expand the company’s tissue-based and liquid biopsy portfolio and its global commercial footprint to support growth.